1,161 Shares of Intuitive Surgical, Inc. $ISRG Bought by Plancorp LLC

Plancorp LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, HoldingsChannel reports. The firm purchased 1,161 shares of the medical equipment provider’s stock, valued at approximately $502,000.

Other hedge funds also recently made changes to their positions in the company. May Hill Capital LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $300,000. Waycross Partners LLC boosted its holdings in shares of Intuitive Surgical by 11.6% during the third quarter. Waycross Partners LLC now owns 71,310 shares of the medical equipment provider’s stock worth $28,997,000 after acquiring an additional 7,397 shares during the period. Alps Advisors Inc. boosted its holdings in shares of Intuitive Surgical by 6.2% during the third quarter. Alps Advisors Inc. now owns 7,419 shares of the medical equipment provider’s stock worth $3,017,000 after acquiring an additional 432 shares during the period. Ashton Thomas Private Wealth LLC grew its position in shares of Intuitive Surgical by 2.2% in the third quarter. Ashton Thomas Private Wealth LLC now owns 2,494 shares of the medical equipment provider’s stock valued at $1,014,000 after purchasing an additional 54 shares during the last quarter. Finally, International Assets Investment Management LLC grew its position in shares of Intuitive Surgical by 9.8% in the third quarter. International Assets Investment Management LLC now owns 3,550 shares of the medical equipment provider’s stock valued at $1,424,000 after purchasing an additional 317 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $452.80 on Monday. The firm has a 50-day moving average price of $409.93 and a two-hundred day moving average price of $431.89. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The company has a market capitalization of $156.96 billion, a P/E ratio of 54.75, a P/E/G ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period last year, the firm earned $2.40 earnings per share. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insider Buying and Selling

In related news, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 49,128 shares of company stock valued at $21,614,167 in the last ninety days. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Wells Fargo & Company reiterated an “overweight” rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Oppenheimer restated an “outperform” rating and issued a $500.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Stifel Nicolaus decreased their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Truist Financial decreased their price objective on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Finally, Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $493.54.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Intuitive Surgical Profile